PIAS-1 Is a Checkpoint Regulator Which Affects Exit from G1 and G2 by Sumoylation of p73
Open Access
- 1 December 2004
- journal article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 24 (24) , 10593-10610
- https://doi.org/10.1128/mcb.24.24.10593-10610.2004
Abstract
P73 is a recently described member of the p53 family, and, like p53, it undergoes a number of posttranslational modifications. Here we show, by yeast two-hybrid screening, pull-down assays, and coimmunoprecipitation, that p73α, -β, and -γ bind to the protein inhibitor of activated STAT-1 (PIAS-1) and that this binding stabilizes p73. PIAS-1 also sumoylates p73α, although not the C-terminally truncated isoforms p73β and -γ, and this requires the RING finger domain of PIAS-1. The ΔNp73α isoform can also bind, and be sumoylated by, PIAS-1. PIAS-1-mediated sumoylation decreases p73 transcriptional activity on several target promoters, such as Bax. p73 is colocalized in the nucleus with PIAS-1, and sumoylated p73 is located exclusively in the nuclear matrix. PIAS-1 is expressed predominantly during S phase, and PIAS-1 overexpression reduces p73-mediated transcription of p21, with a reduction of cells in G1 and cell cycle reentry. Inhibition of endogenous PIAS-1 by RNA interference reduces the proportion of cells in S phase and induces G2 arrest. These data suggest that PIAS-1, acting partly through binding and sumoylation of p73, is an important component of the cell cycle machinery.Keywords
This publication has 43 references indexed in Scilit:
- PIAS proteins promote SUMO-1 conjugation to STAT1Blood, 2003
- The ‘PINIT’ motif, of a newly identified conserved domain of the PIAS protein family, is essential for nuclear retention of PIAS3LFEBS Letters, 2003
- c-Abl Tyrosine Kinase Selectively Regulates p73 Nuclear Matrix AssociationJournal of Biological Chemistry, 2003
- SUMO Modification of STAT1 and Its Role in PIAS-mediated Inhibition of Gene ActivationJournal of Biological Chemistry, 2003
- Ascorbate up-regulates MLH1 (Mut L homologue-1) and p73: implications for the cellular response to DNA damageBiochemical Journal, 2002
- Activation of p53 by Protein Inhibitor of Activated Stat1 (PIAS1)Published by Elsevier ,2002
- The two faces of p73Cell Death & Differentiation, 2002
- Functional analysis and intracellular localization of p53 modified by SUMO-1Oncogene, 2001
- New p73 variants with altered C-terminal structures have varied transcriptional activitiesOncogene, 1999
- Improved method for high efficiency transformation of intact yeast cellsNucleic Acids Research, 1992